The Impact of Allergic Rhinitis On Employee Health and Productivity
A Report from the Wellness Inventory
Donald H. Gemson, MD, Medical Director, Merrill Lynch
Benjamin Eng, MD, Senior Medical Director, Pfizer Inc
Health conditions prevalent among employees and the family members they care
for significantly affect employee absenteeism, workplace productivity, and employer
costs.1 As a result, employers have demonstrated a growing interest
in identifying the conditions that have the greatest impact on their employees
health and implementing targeted interventionssuch as physician-led health
education classesto promote employee wellness. This interest is reflected
in employers increased use of the Wellness Inventory, a survey-based program
developed by Pfizer Inc and The MEDSTAT Group. The Wellness Inventory has consistently
found allergic rhinitis to have a significant impact on employee productivity
and employer costs.1,2
Allergic Rhinitis: Quick Stats3 US prevalence: 40 million people, including 19 million employed
adults Associated costs: $4.5 billion in direct costs per year Impact: 3.8 million lost work and school days |
Tested for validity and reliability, the Wellness Inventory assesses the impact
of 11 medical conditions and four caregiver conditions on employee wellness,
productivity, and associated costs. The 11 medical conditions are
- allergic rhinitis
- anxiety
- arthritis
- asthma
- coronary heart disease (CHD)
- depression
- diabetes
- hypertension
- migraine
- respiratory illnesses, and
- stress.
The caregiver conditionsconditions affecting someone for whom the employee
provides careinclude Alzheimer's disease, otitis media, pediatric allergies,
and pediatric respiratory illnesses.1
The Wellness Inventory, a completely anonymous survey, takes only a few minutes
for employees to complete. It features 53 questions that capture the prevalence
and impact of specific conditions in the preceding 12 months.
The Wellness Inventory: Quick Stats2 Designed in 2001 by Pfizer Inc and The MEDSTAT Group Tested for reliability4 and validity5 Implemented among more than 120 employers Completed by more than 36,000 employees Used by employers across a range of industrieshealthcare,
financial, manufacturing, utilities, state and municipal agencies, and
school systems Aggregate data identify rhinitis as the most common condition and
as having the greatest impact on employee productivity/costs, reflecting
its high prevalence |
The Impact of Allergic Rhinitis
Allergic rhinitis affects some 40 million people in the United States.3 In 2001, allergic rhinitis prompted 12 million physician office visits.6 Further, the disease has been associated with estimated direct medical costs
of $4.5 billion per yearand approximately 3.8 million lost work and school
days.3
The Wellness Inventory has repeatedly identified allergic rhinitis as the most
common medical condition and the condition having the greatest impact on absenteeism
and presenteeismdecreased productivity at work due to health problems.
Several sourcesfindings from a multiemployer study, aggregate data from
the Wellness Inventory, and a single-employer case studysuggest a high
prevalence, significant impact, and substantial cost associated with allergic
rhinitis.
A Multiemployer Study
Findings from a recent study among more than 8,000 employees at 47 locations
showed that 55% of workers experienced allergic rhinitis. Of all conditions,
allergic rhinitis was associated with the highest costs from lost productivity,
with a mean productivity loss of $593 per employee per year1 (Figure
1).
Figure 1. Average total productivity loss per employee surveyed1

Click here to view full-size graphic
* P<.05 for allergic rhinitis versus other conditions.
N=8267.
Adapted from Lamb et al. 1
Employees affected by rhinitis/hay fever reported experiencing symptoms for
an average of 52.5 days per year, being absent 3.6 days per year, and losing
2.3 hours of productivity each workday while symptomatic at work.1 The net result: lost productivity costs totaling an estimated $4.9 million per
year.1
Further, 7% of employees reported acting as caregivers for children with allergies.1 Associated lost productivity costs were estimated to be $85 per year per affected
employee, or a total of $700,000 from the more than 8,000 employee sample.1
Results of this study reveal the economic burden of allergies in the workplace,
totaling $5.6 million per year among the 8,000 employees surveyed.1 The findings from this multiemployer study are consistent with the results of
the Wellness Inventory data captured from all surveys conducted since the program
was first implemented in 2001.
Data from the Wellness Inventory2
The expanded data set of more than 36,000 surveys completed since the debut
of the Wellness Inventory in 2001which include the more than 8,000 employee
responses discussed abovealso demonstrates the high prevalence and impact
on productivity of allergic rhinitis. These data identify allergic rhinitis
as the most common medical condition among employees surveyed. On average, allergic
rhinitis was experienced by 56% of employees surveyed (Figure 2). The condition
had the highest costs associated with absenteeism ($10 million, or $496 per
employee) and presenteeism ($13 million, or $645 per employee) for a total cost
of nearly $23 million ($1,140 per employee) in lost productivity (Figure 3).
Among caregiver conditions, pediatric allergies were associated with the highest
presenteeism costs ($1.6 million, or $624 per employee).
Figure 2. Percent of respondents reporting the selected condition during
the survey period2*

Click here to view full-size graphic
*N=36010.
Figure 3. Estimated annual combined cost of presenteeism amd absenteeism
for all affected respondents2

Click here to view full-size graphic
Many employers may not yet recognize the prevalence and impact of allergic
rhinitis on their work force. However, the impact of this condition on productivity
and employer costs emphasizes the need to give more attention to this condition.
Employer Case StudyMerrill Lynch2
In October 2002, the Wellness Inventory was implemented at three Merrill Lynch
sites in the northeast. Incorporated as part of a large employee health fair
and promoted to employees prior to the event, the Wellness Inventory was completed
by more than 2,000 employees.
Although these responses are also included in the aggregate data, the results
for this employer demonstrate the need for wellness interventions targeted to
allergy. Fifty-nine percent of Merrill Lynch employees reported experiencing
allergic rhinitis during the preceding 12 months. This condition was associated
with significant costs in lost productivitya total of nearly $820 per
employee.2
As a result of these findings, Merrill Lynch offered an "Allergy 101"
educational lecture the following allergy season in April and May 2003. Anticipating
that the prevalence and impact of rhinitis would be similar among employees
at other Merrill Lynch locations, the company made the lecture available at
a total of five sites.
The course was led by various physicians from the community who presented information
about rhinitis. The lecture was structured as a 1-hour meeting with a 40-minute
presentation and a 20-minute question-and-answer session. A medication effectiveness
survey administered at each lecture helped assess how well various over-the-counter
and prescription medications relieved employees allergy symptoms and which
ones employees believed were most effective.
Since the Wellness Inventory provides employers with an anonymous sample of
information about employee health status, it is impossible to track individual
employee outcomes. The resource was not designed to measure such outcomes. Rather,
the Wellness Inventory was created to allow employers to identify areas of opportunity
and to subsequently craft an action plan that helps target those areas, as Merrill
Lynch has done.
Merrill Lynch presented the findings at the National Business Group on Health
in November 2003. In addition, Merrill Lynch plans to offer the Wellness Inventory
and "Allergy 101" intervention course again in the future.
"Pfizer partners with employers to help them define and benchmark employee
health and quantify the economic impact to develop interventions that directly
address employee needs and improve employee health and productivity," says
Jane Newman, RN, MPH, National Employer Account Manager of Pfizer, Inc, who
partnered with Merrill Lynch to implement the Wellness Inventory. "Merrill
Lynch used the Wellness Inventory to identify key conditions affecting their
employees so the company could best meet the needs of its workers."
This case study demonstrates the data-driven approach companies can take when
they employ a comprehensive strategy to improving employee health and productivityone
that includes not only identifying conditions affecting employee wellness and
job performance but also implementing interventions to help improve health and
productivity. It also shows that survey data can be used to expand the focus
of disease management outside of the usual target conditions (eg, asthma, diabetes)
to include those that affect productivity of a large number of employees.
Conclusion
As employers increasingly assess the relationship between employee health and
productivity, many are identifying a significant impact for allergic rhinitis.
Data from the Wellness Inventory have been used to better understand absenteeism
and presenteeism and to initiate interventions as part of a targeted approach
to improving employee health and workplace productivity. Findings from studies
using a tool such as the Wellness Inventory suggest that employers should consider
the total costs, including productivity, of allergic rhinitis and other prevalent
health conditions when designing employee benefits packages.
REFERENCES
1. Lamb CE, Ratner PH, Johnson CE, Ambeganonkar AJ, Sampson
N, Eng B. Economic impact of allergic rhinitis on productivity in the workplace.
Presented at the American Academy of Allergy, Asthma and Immunology annual meeting, April 2003.
Data on file, Pfizer Inc.
2. The Allergy Report: Disease of the Atopic Diathesis. Vol 2. Milwaukee, WI: The American Academy of Allergy, Asthma & Immunology,
Inc; 2000.
3. Goetzel RZ, Ozminkowski RJ, Long SR. Development and reliability
analysis of the Work Productivity Short Inventory (WPSI) instrument measuring
employee health and productivity. J Occup Environ Med. 2003;45:743-762.
4. Ozminkowski RJ, Goetzel RZ, Long SR. A validity analysis
of the Work Productivity Short Inventory (WPSI) instrument measuring employee
health and productivity. J Occup Environ Med. 2003;45:1183-1195.
5. National Center for Health Statistics. Allergies/hay fever.
Available at: http://www.cdc.gov/nchs/fastats/allergies.htm.
Accessed March 28, 2004.
Donald Gemson, Benjamin Eng. The Impact of Allergic Rhinitis On Employee Health and Productivity. Business and Health August 2004;22.